Use of Nalpuphine in post operative pain

Does Gender Affect the Response to the Use of Intravenous Nalbuphine for Post Operative Analgesia after Major Abdominal Surgery; A multicenter Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201304000486309

Enrollment

160

Registered

2013-01-16

Start date

2013-02-03

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Gender Difference in Response to Nalpuphine, post operative pain

Interventions

GROUP 1 MALE

GROUP 2 MALE

GROUP 3 FEMALE

GROUP 4 FEMALE

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1-Age: 18-65 years old 2-Male & Female patients of ASA physical status I to III 3-Scheduled for elective major abdominal surgery

Exclusion criteria

Exclusion criteria: 1-Patients with a definite diagnosis of chronic pain syndrome, psychiatric disorders or drug abuse 2-Intraoperative fentanyl use 3-Patients with definite diagnosis of esophageal reflux syndrome 4-Usage of sedatives, antiemetics or antipruritics within 24 hours before operation 5-Surgery (more than 4 hours or laparoscopy)

Design outcomes

Primary

Measure	Time frame
Pain with reference to Gender	—

Secondary

Measure	Time frame
side effects	—

Countries

Egypt

Contacts

Public ContactAyman Onsy

Marketing Director

aonsy@amoun.com46140100

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026